Rationale for New Drugs Targeting the Tissue Microenvironment in Patients with HCC

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|13|32|3288-3291

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.13, Iss.32, 2007-11, pp. : 3288-3291

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Drugs targeting the bone microenvironment: new therapeutic tools in Ewing's sarcoma?

By Redini Francoise   Odri Guillaume A   Picarda Gaëlle   Gaspar Nathalie   Heymann Marie-Françoise   Corradini Nadege   Heymann Dominique  

Expert Opinion on Emerging Drugs, Vol. 18, Iss. 3, 2013-09 ,pp. : 339-352

Informa Healthcare

Access to resources Recommend Favorite

The Rationale and Development of New Drugs to Treat HIV Infection

By  

Medicinal Chemistry, Vol. 1, Iss. 6, 2005-11 ,pp. : 635-642

Bentham Science Publishers

Access to resources Recommend Favorite

Targeting the Leukemia Microenvironment

By  

Current Drug Targets, Vol. 8, Iss. 6, 2007-01 ,pp. : 685-701

Bentham Science Publishers

Access to resources Recommend Favorite

Tumoural Expression of Connective Tissue Growth Factor (CTGF) Impacts on Survival in Patients Diagnosed with Hepatocellular Carcinoma (HCC)

By  

Current Cancer Drug Targets, Vol. 15, Iss. 5, 2015-01 ,pp. : 435-444

Bentham Science Publishers

Access to resources Recommend Favorite

Targeting Inflammation in Cancer-Related-Fatigue: A Rationale for Mistletoe Therapy as Supportive Care in Colorectal Cancer Patients

By  

Inflammation & Allergy-Drug Targets (Formerly Current Drug Targets - Inflammation & Allergy), Vol. 13, Iss. 2, 2014-05 ,pp. : 105-111

Bentham Science Publishers

Access to resources Recommend Favorite